NERV - Minerva Neurosciences Corp Bozor kapitallashuvining daromadga nisbati
FDA da'volaridan keyingi investorlar ehtiyoti, P/S bozor ko'rsatkichi bilan ko'rsatilganidek, kotirovkalarga bosim o'tkazdi. ning joriy darajasi shizofreniya bemorlarining ijtimoiy moslashuvi uchun vositalarni ishlab chiquvchi biznes — Minerva Neurosciences (NERV) kompaniyasining baholanishini aks ettiradi. Minerva Neurosciences (NERV) barqarorligi uyqu buzilishlari va surunkali psixozlarni davolash patentlariga asoslangan bo'lib, ular mahsulotlarga doimiy talabni ta'minlaydi.
Minerva Neurosciences Corp (NERV) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Minerva Neurosciences|NERV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Minerva|NERV - Kompaniya qarzlari|Balans qiymatiga qarzlar Minerva Neurosciences Corp|NERV - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Minerva Neurosciences|Tezkor likvidlik ko‘rsatkichi minervaneurosciences.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
NERV - Sof foyda|Kompaniya foydasi prognozi Minerva Neurosciences|NERV - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Minerva Neurosciences Inc|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Minerva Neurosciences Corp|NERV - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Minerva Neurosciences|NERV - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi minervaneurosciences.com|NERV - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Minerva Neurosciences
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:NERV - minervaneurosciences.com
Shizofreniya davolash vositalariga bo‘lgan barqaror talab Minerva Neurosciences (NERV) kompaniyasiga yuqori makroiqtisodiy chidamlilikni ta’minlaydi. Sotuvlar nisbatini (price-to-sales multiple) tahlil qilish orqali investor joriy bozor kapitalizatsiyasini generatsiya qilingan real daromadlar hajmi bilan solishtiradi. Ushbu ko‘rsatkich sotuvlarning har bir dollari uchun xarajatni belgilab, fundamental o‘sishni spekulyativ qizishdan ajratish imkonini beradi. Bunday baholash daromadlari bozor sharoitlaridan mustaqil qolgan sikllardan tashqari biotexnologiya kompaniyasining investitsiyaviy jozibadorligini tasdiqlaydi.
Minerva Neurosciences raqobatchilari
P/S multiplikatori biogen.com (BIIB)|Neurocrine Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati RGC|AXSM - Narxning daromadga nisbati|ACAD (ACADIA Corp) - Kapitalizatsiya va daromad nisbati|XENE: P/S multiplikatori|Sotuvga nisbatan narx vikingtherapeutics.com (VKTX)|Kapitalizatsiyaning daromadga nisbati SUPN|P/S multiplikatori Catalyst Pharma|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|HRMY (Harmony Corp) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Biohaven Ltd. BHVN|amylyx.com (AMLX) - Sotuvga nisbatan narx|TRVI - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Precision Medicines Inc PRAX|AVXL: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CeriBell EEG|PRTA (Prothena Biosciences) - P/S multiplikatori|Alector Therapeutics (ALEC) - Narx/daromad koeffitsiyenti|P/S multiplikatori ANNX|OMER - Sotuvga nisbatan narx|Narxning daromadga nisbati Neurogene Corp NGNE|ACIU: Kapitalizatsiya va daromad nisbati|Voyager Therapeutics - P/S multiplikatori|neumoratx.com (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|Sotuvga nisbatan narx Tevogen Bio Holdings Inc. (TVGN)|Narxning daromadga nisbati Alpha Cognition Inc|Cognition Therapeutics Inc. (CGTX) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Inhibikase Therapeutics (IKT)|cassavasciences.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - Sotuvga nisbatan narx|VTGN - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati OVID (Ovid Therapeutics Inc.)|ABOS (Acumen Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|CRVO (cervomed.com) - Narxning daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Ltd.|Kapitalizatsiya va daromad nisbati CLNN (Clene Nanomedicine)|P/S multiplikatori PEPG|JUNS - Sotuvga nisbatan narx|Relmada Therapeutics - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori annovisbio.com ANVS|GRCE - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati AIFF (Firefly Neuroscience, Inc.)|anewmeds.com (KLTO) - Narxning daromadga nisbati|Sotuvga nisbatan narx NeuroSense Therapeutics Ltd. (NRSN)|Narxning daromadga nisbati Reviva Pharmaceuticals|Kapitalizatsiyaning daromadga nisbati MetaVia, Inc. (MTVA)|P/S multiplikatori NRXS|Narx/daromad koeffitsiyenti heliusmedical.com|Narxning daromadga nisbati Passage Bio PASG|NEUP: Kapitalizatsiya va daromad nisbati|Athira Pharma, Inc. - P/S multiplikatori|Sotuvga nisbatan narx addextherapeutics.com|alzamend.com (ALZN) - Narxning daromadga nisbati|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|Narxning daromadga nisbati KTTA|P/S multiplikatori CRGT|P/S multiplikatori avenuetx.com (ATXI)|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CARA|CHRO - Narxning daromadga nisbati|ELYM (Eliem Therapeutics) - Kapitalizatsiya va daromad nisbati|ITCI: P/S multiplikatori|Sotuvga nisbatan narx longboardpharma.com (LBPH)|Kapitalizatsiyaning daromadga nisbati MRNS|P/S multiplikatori NKGen Biotech Inc|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|trevena.com (TRVN) - Sotuvga nisbatan narx|VIGL - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti anewmeds.com WENA|CERE: P/S multiplikatori
